Skip to main content
. 2021 Apr 3;901:174082. doi: 10.1016/j.ejphar.2021.174082

Fig. 7.

Fig. 7

BE for virtual hit compounds. The violet line shows the cut-off range for the compounds selected. (A) FDA approved compounds, (B) PubChem COVID-19 clinical trial compounds, (C) NPASS database compounds and (D) Maybridge database compounds.